Marc-André Langlois

29PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromoleculesMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jan 27, 2026
Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Sita Bhella, Gerard Agbayani, Katrina Hueniken

|May 07, 2025
Systemic and Mucosal Antibody Responses to SARS-CoV-2 Variant-Specific Prime-and-Boost and Prime-and-Spike Vaccination: A Comparison of Intramuscular and Intranasal Bivalent Vaccine Administration in a Murine Model.

Mariam Maltseva, Yannick Galipeau, Pauline McCluskie

|Apr 26, 2025
Characterization of Nanobody Binding to Distinct Regions of the SARS-CoV-2 Spike Protein by Flow Virometry.

Mariam Maltseva, Martin A Rossotti, Jamshid Tanha

|Feb 14, 2025
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.

Yannick Galipeau, Nicolas Castonguay, Pauline S McCluskie

|Jan 31, 2025
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.

Philip Samaan, Chapin S Korosec, Patrick Budylowski

|Dec 27, 2024
Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada.

Kim Santerre, Mathieu Thériault, Nicholas Brousseau

Pageof 5

Frequent Collaborators

5 joint publications

Curtis L Cooper

4 joint publications

Mariam Maltseva

3 joint publications

Angela M Crawley

3 joint publications

Yves Durocher